Skip to main content
Sanofi India Ltd logo

Sanofi India Ltd — Investor Relations & Filings

Ticker · SANOFI ISIN · INE058A01010 LEI · 335800VFWLEY5V6PYH80 BSE.NS Manufacturing
Open in API
Filings indexed 1,554 across all filing types
Latest filing 2019-09-17 Regulatory Filings
Country IN India
Listing BSE.NS SANOFI

About Sanofi India Ltd

https://www.sanofi.in

Sanofi India Ltd focuses on the development, manufacturing, and marketing of a wide range of pharmaceutical products and healthcare solutions. The company operates across several therapeutic areas, including diabetes, cardiology, thrombosis, central nervous system disorders, and consumer healthcare. Its product portfolio includes established brands such as Lantus, Allegra, Combiflam, Amaryl, Avil, and Enterogermina. The organization prioritizes chronic disease management and acute care through a combination of prescription medicines and over-the-counter treatments. By integrating global research capabilities with local manufacturing excellence, the company provides specialized medical solutions aimed at improving patient health outcomes and addressing unmet medical needs.

Recent filings

Filing Released Lang Actions
Pursuant to Regulation 39 (3) of SEBI (Listing Obligations and Disclosure Requirements), Regulations 2015, we would like to inform you that the Company has issued duplicate share certificates ....
Regulatory Filings
2019-09-17 English
Press Release
Capital/Financing Update Classification · 95% confidence The document is a press release announcing the Board of Directors' approval of a slump sale and transfer of a manufacturing facility from Sanofi India Limited to Zentiva. It discusses the transaction details, strategic rationale, and background information about the site and company. There are no financial statements, detailed financial performance data, or regulatory form references. The document is an announcement of a corporate transaction approved by the board, not a full report or filing. It fits best under Capital/Financing Update (CAP) as it relates to a significant asset sale and corporate restructuring approved by the board and subject to shareholder approval.
2019-09-11 English
Press Release - Sanofi India Limited to sell Ankleshwar site to Zentiva We enclose herewith a copy of press release on the above subject, contents of which are self-explanatory ....
Capital/Financing Update Classification · 95% confidence The document is a press release announcing the Board of Directors' approval of a slump sale and transfer of a manufacturing facility by Sanofi India Limited. It includes details about the transaction, the site being sold, and company background information. There are no financial statements, detailed financial performance data, or comprehensive report content. The document is relatively short (3501 characters) and serves as an announcement rather than a full report. It does not fit categories like Annual Report, Interim Report, or Earnings Release. It is not a regulatory filing or certification. The content is about a corporate transaction approval by the Board and is presented as a press release. Therefore, the most appropriate classification is Capital/Financing Update (CAP), which covers updates on company fundraising, financing activities, or capital structure changes, including asset sales and transfers approved by the Board.
2019-09-11 English
Outcome of Board Meeting
Capital/Financing Update Classification · 95% confidence The document text provides details about a transaction involving the sale or disposal of a business unit, including dates, consideration amount, buyer details, and whether it is a related party transaction. It does not contain financial statements or comprehensive financial performance data. The content is focused on a specific capital transaction rather than a full report or announcement of voting results. The document length is short (1458 characters), and it is not a report publication announcement or certification. The nature of the content aligns with updates on company fundraising, financing activities, or capital structure changes, which fits the Capital/Financing Update category.
2019-09-11 English
Slump Sale and transfer of the manufacturing facility of the Company at Ankleshwar, Gujarat. The Board of Directors of Sanofi India Limited (the Company) at its meeting held on ....
Capital/Financing Update Classification · 95% confidence The document is a formal announcement addressed to stock exchanges regarding the approval by the Board of Directors of Sanofi India Limited for a slump sale and transfer of a manufacturing facility. It details the transaction terms, strategic rationale, valuation, and regulatory disclosures under SEBI Listing Obligations. The document does not contain financial statements or detailed financial performance data but rather describes a corporate transaction and its expected impact. It is not an annual or interim report, earnings release, or audit report. It is also not a merger proxy or tender offer filing but relates to a significant asset sale. The document fits best as a Capital/Financing Update (CAP) because it announces a material transaction affecting the company's asset base and business operations, including consideration and expected completion date. The length and detail confirm it is not a brief announcement or a simple regulatory filing. Therefore, the classification is CAP with high confidence.
2019-09-11 English
Pursuant to Regulation 39 (3) of SEBI (Listing Obligations and Disclosure Requirements), Regulations 2015, we would like to inform you that the Company has issued duplicate share certificates ....
Share Issue/Capital Change Classification · 95% confidence The document is a short notification addressed to stock exchanges regarding the issuance of duplicate share certificates due to loss or misplacement. It references Regulation 39(3) of SEBI (Listing Obligations and Disclosure Requirements) but does not contain financial data, management discussion, or report content. It is an announcement about a share certificate issue, which fits the category of Share Issue/Capital Change (SHA) as it relates to changes in share certificates and capital records. The document length is short and it is not a report or a certification, so it is not RNS or RPA. Therefore, the appropriate classification is SHA.
2019-08-22 English

Browse filings by year

17 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.